StockVS

NYSE · Medical Devices · USD

Koninklijke Philips N.V. (PHG) Stock Analysis

Koninklijke Philips N.V. (PHG) is a Medical Devices stock listed on NYSE and quoted in US Dollar.

PHG

$25.89

−$0.16 (−0.61%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare PHG with… →

PHG Key Statistics

As of Sep 4, 2026
Trading
Open
$25.91
Previous Close
$26.05
Day's Range
25.86–26.02
52-Week Range
23.85–33.44
Volume
455.40K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.91
Valuation
Market Cap
$25.31B
P/E Ratio
19.76
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
13.60
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.78
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
1.43
EPS (ttm)Profit attributable to each share over the last twelve months.
1.31
Financials (FY)
Revenue (FY)
$17.83B−1.04%
Net Income (FY)
$895.00M
Profit marginThe share of revenue left as profit after all costs and taxes.
6.31%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
977.43M
1-Year Return
−3.00%
Dividend and dates
Dividend
$1.01+3.89%
Ex-Dividend Date
May 13, 2026
Earnings Date
November 3, 2026
Avg Volume
1.05M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

PHG Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−0.67%
2025+11.25%
2024+8.53%
2023+55.64%
2022−57.64%
2021−30.75%
2020+11.00%
2019+42.23%
2018−4.92%
2017+26.68%
2016 (partial year)+13.85%

As of September 4, 2026.

PHG Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$17.83B$895.00M5.0%
2024$18.02B−$702.00M−3.9%
2023$18.17B−$466.00M−2.6%
2022$17.83B−$1.61B−9.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$17.83B$8.06B$1.45B$895.00M5.0%
2024$18.02B$7.77B$513.00M−$702.00M−3.9%
2023$18.17B$7.45B−$168.00M−$466.00M−2.6%
2022$17.83B$7.19B−$177.00M−$1.61B−9.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

PHG Dividend History

$0.97

Dividends per share, 2025 · 1 payments

YearDividends per sharePaymentsChange
2026*$1.011
2025$0.971
2022$0.961−6.7%
2021$1.031
YearDividends per sharePaymentsChange
2026 (partial year)$1.011
2025$0.971
2022$0.961−6.7%
2021$1.031
2019$0.961−3.2%
2018$0.991+14.9%
2017$0.861

Most recent payment: $1.01 per share, ex-dividend May 13, 2026. Per-share amounts summed by calendar year from ex-dividend dates. Partial years are shown muted and marked with an asterisk.

PHG Valuation vs Medical Devices Median

Median of 151 stocks
MetricPHGMedical Devices medianvs median
P/E19.7626.8026% below
P/S ratio1.432.9852% below
Profit margin6.31%−1.69%8.0 pts above

Medians across 151 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Koninklijke Philips N.V. (PHG) at $25.31B. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 63,670 employees.

The 52-week range on file runs from $23.85 to $33.44. PHG last closed at $25.89 on September 4, 2026. That is −$0.16 (−0.61%) against the previous close. The latest close sits 8.55% above that 52-week low.

Financial Health

In fiscal 2025, Koninklijke Philips N.V. reported revenue of $17.83B. That is −1.04% against the prior fiscal year, when revenue was $18.02B. Net income for the same year was $895.00M. The reported profit margin is 6.31%. That is 8 percentage points above the Medical Devices median of −1.69%. Trailing earnings per share are 1.31.

Across the 4 fiscal years on file, revenue moves from $17.83B in 2022 to $17.83B in 2025. Of those 4 years, 1 report positive net income.

Valuation Assessment

On trailing earnings, the shares are priced at 19.76 times earnings. That is 26.27% below the Medical Devices median of 26.8. On forward earnings the ratio is 13.6. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.78. Measured against sales, the shares trade at 1.43 times revenue. On price-to-sales that is 51.87% below the Medical Devices median of 2.98. The medians here are taken across 151 Medical Devices companies that report the metric.

The reported beta is 0.91. Daily returns over the trailing 10 years annualize to a volatility of 31.92%. The trailing one-year price return is −3.00%. Across 10 years the annualized return works out at +0.73%.

Growth & Income

PHG pays a dividend yielding 3.89%. That is 2.5 percentage points above the Medical Devices median yield of 1.38%. The indicated annual rate is $1.01 a share. The ex-dividend date on file is May 13, 2026. Dividends are recorded for 7 calendar years; 2026 shows 1 payments totalling $1.01 a share. The year before, 2025, totalled $0.97 a share.

Across the complete calendar years on file, 2023 returned +55.64% and 2022 returned −57.64%. Of the 9 complete calendar years on file, 6 finished higher. 2026 is still running; the price is −0.67% year to date.

Peer Comparison

Koninklijke Philips N.V. (PHG) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Koninklijke Philips N.V. PHG $25.31B 19.8
Abbott Laboratories ABT $187.45B 35.1
Medtronic plc. MDT $120.46B 22.9
Stryker Corporation SYK $116.27B 31.9

The Medical Devices industry average P/E ratio is 26.8x. Koninklijke Philips N.V. trades at a P/E of 19.8.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Medical Devices Stocks

View all Medical Devices stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Koninklijke Philips N.V.

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. It operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. The company provides diagnostic imaging solutions, includes ultrasound business unit, magnetic resonance imaging, computed tomography, and diagnostic x-ray; Image Guided Therapy, including image guided therapy systems and image guided therapy devices. It also offers monitoring, enterprise informatics, and sleep and respiratory care, as well as personal health. Koninklijke Philips N.V. has strategic alliance with WellSpan Health to advanced imaging and diagnostics technology products and platforms. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Visit website →